Research Article
Adrenal Vein Sampling in the Management of Primary Aldosteronism: The Added Value of Intraprocedural Cortisol Assessment
Table 1
Characteristics of patients submitted to adrenal vein sampling.
| | Preintraprocedural cortisol measurement (n = 19) 2016–September 2021 | Postintraprocedural cortisol measurement (n = 24) October 2021–December 2022 | value | Total (n = 43) |
| Age (years) | 0.45 | | Mean (SD) | 56.4 (±8.2) | 54.3 (±9.4) | 55.2 (±8.9) | Minimum | 40 | 32 | 32 | Maximum | 73 | 73 | 73 | Gender | 0.60 | | Female, n (%) | 11 (57.9%) | 12 (42.1%) | 23 (53.5%) | Age at hypertension diagnosis | 0.59 | | Mean (SD) | 41.2 (±10.6) | 43.1 (±12.3) | 42.3 (±11.5) | Minimum | 21 | 34 | 15 | Maximum | 60 | 52 | 67 | Age at PA diagnosis | 0.48 | | Mean (SD) | 53. (±9.6) | 51.2 (±9.5) | 52.1 (±9.5) | Minimum | 34 | 49 | 31 | Maximum | 72 | 70 | 72 | The interval between hypertension and PA diagnosis (years) | 0.20 | | Mean | 12.1 (±10.6) | 8.0 (±9.1) | 9.8 (±9.9) | Minimum | 2 | 0 | 0 | Maximum | 41 | 25 | 41 | Number of antihypertensive medication | 0.06 | | Mean (SD) | 3.2 (±0.98) | 2.5 (±1.2) | 2.8 (±1.1) | Minimum | 1 | 1 | 1 | Maximum | 4 | 5 | 5 | Complications | 7 (36.8%) | 4 (16.7%) | 0.13 | 11 (25.6%) | Retinopathy | 1 (5.3%) | 1 (4.2%) | 0.87 | 2 (4.7%) | Cardiopathy | 5 (26.3%) | 3 (12.5%) | 0.13 | 8 (18.6%) | Nephropathy | 0 (0%) | 2 (8.3%) | 0.20 | 2 (4.7%) | Cerebrovascular | 3 (15.8%) | 1 (4.2%) | 0.19 | 4 (9.3%) | Encephalopathy | 0 (0%) | 1 (4.2%) | 0.37 | 1 (2.3%) | Hypokalemia | 13 (68.4%) | 14 (58.3%) | 0.50 | 27 (62.8%) | Mean serum K+ (mmoL/L) (SD) | 3.0 (±0.4) | 3.0 (±0.2) | 3 (±0.34) | Imaging (CT) | 0.95 | | Normal adrenals | 3 (15.8%) | 3 (8.3%) | 6 (14%) | Right-sided unilateral nodes | 7 (36.8%) | 9 (37.5%) | 16 (37.2%) | Left-sided unilateral nodes | 5 (26.3%) | 8 (33.3%) | 13 (30.2%) | Bilateral nodes | 3 (15.8%) | 2 (8.3%) | 5 (11.6%) | Right adrenal hyperplasia | 1 (5.3%) | 0 | 1 (2.3%) | Left adrenal hyperplasia | 0 | 2 (8.3%) | 2 (4.8%) |
|
|
SD, standard deviation.
|